Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. - Cardet JC; Jiang X; Lu Q; Gerard N; McIntire K; Boushey HA; Castro M; Chinchilli VM; Codispoti CD; Dyer AM; Holguin F; Kraft M; et al. (The Journal of allergy and clinical immunology, 2019)